The Successful Implementation of a Modified Pediatric Acute Lymphoblastic Leukemia Protocol to Treat an Elderly
Ibraheem H Motabi1, Yara A Alsaif2, Mohammed K Bin Shuayl3
1Hematology and Medical Oncology, King Fahad Medical City, Riyadh, SAU.
Insights
This case report details the successful treatment of a 67-year-old male with T-cell acute lymphoblastic leukemia (T-ALL) using a modified pediatric protocol. The findings suggest this approach is safe and effective for elderly ALL patients.
Area of Science:
- Hematology
- Oncology
- Clinical Medicine
Background:
- Acute lymphoblastic leukemia (ALL) is a prevalent pediatric hematological malignancy.
- T-cell ALL (T-ALL) in adults presents with lymphadenopathy, hepatosplenomegaly, immunosuppression, and hypercalcemia.
- Limited research exists on treating elderly ALL patients (over 60) with modified pediatric regimens.
Observation:
- A 67-year-old male was diagnosed with T-ALL.
- The patient was treated using a modified Children's Oncology Group (COG) protocol, typically used for pediatric patients.
- The treatment demonstrated positive outcomes for the elderly patient.
Findings:
- The modified COG protocol proved to be an effective treatment for T-ALL in an elderly patient.
- The regimen was found to be safe and efficacious in this specific case.
- This case highlights a potential treatment strategy for older adults with T-ALL.
Implications:
- Modified pediatric ALL protocols may be a viable option for elderly patients.
- Further research is warranted to validate the efficacy and safety of this approach in a larger geriatric ALL cohort.
- This case contributes to understanding treatment adaptations for T-ALL in older adults.
Abstract:
Acute lymphoblastic leukemia (ALL) is a group of hematological malignancies most commonly seen in pediatrics. The disease process localizes in lymphoid organs, the central nervous system, the mediastinum, and bone marrow (BM). The clinical features of T-cell acute lymphoblastic leukemia (T-ALL) in adults include evidence of generalized lymphadenopathy, hepatosplenomegaly, immunosuppression, and hypercalcemia. There is limited research on the efficacy of using modified pediatric treatment regimens in the elderly over the age of 60 with ALL; this case report aims to illustrate the successful treatment of a 67-year-old male patient diagnosed with T-ALL, using a modified Children's Oncology Group (COG) protocol. Through this, it has been shown to be an effective, safe, and efficacious treatment option for our patient.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018